Tumor Growth Rate Predicts Pathological Outcomes in Breast Fibroepithelial Tumors: A Pilot Study and Review of Literature
As a pilot, this study establishes foundational variance and effect-size estimates for powering a multicenter trial. If validated, TGR may provide an objective, noninvasive metric to enhance preoperative risk stratification and guide management of breast FETs.
Authors
- Nicole Brofman
- M. Jorda
- Carmen Gomez‐Fernandez (ORCID: https://orcid.org/0000-0001-8276-2428)
- Elena Frauke Brachtel
- Hisham F. Bahmad (ORCID: https://orcid.org/0000-0003-3799-2595)
- Karem Gharzeddine
- Abdallah Araji
- Youley Tjendra (ORCID: https://orcid.org/0000-0002-8665-312X)
- Adriana Falcon
- Natalie Pula
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- University of Miami (US)
Publication Details
- Journal
- Cancers
- Published
- 2026-01-15
- DOI
- https://doi.org/10.3390/cancers18020269
- Primary Topic
- Breast Lesions and Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00